US Patent 9879022 Bicyclic-fused heteroaryl or aryl compounds
Patent 9879022 was granted and assigned to Pfizer Limited on January, 2018 by the United States Patent and Trademark Office.
Is a
Date Filed
August 10, 2016
Date of Patent
January 30, 2018
Patent Application Number
15232892
Patent Citations Received
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 9879022 Bicyclic-fused heteroaryl or aryl compounds
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
